Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

1.0K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.0K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

36
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
36
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

90
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
90
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

44
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
44
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

71
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
71
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

40
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
40

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical Management and Mechanical Circulatory Support Escalation in Right Ventricular Failure.

Cardiology clinics·2026
Same author

THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

American heart journal·2026
Same author

The utilization of large bore mechanical thrombectomy and extracorporeal pulmonary resuscitation in catastrophic pulmonary embolism: A case series.

Perfusion·2026
Same author

Unveiling an Uncommon Complication: Pleural Effusion Secondary to Pioglitazone Use.

Journal of community hospital internal medicine perspectives·2026
Same author

Refractory left main coronary vasospasm and electrical storm in a transgender woman: a case report.

European heart journal. Case reports·2025
Same author

Selection Matters: Use of Microaxial Flow Pumps in Acute Myocardial Infarction-Associated Cardiogenic Shock/Danger Shock Trial.

Journal of cardiothoracic and vascular anesthesia·2025

Related Experiment Video

Updated: Sep 22, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K

Cardiogenic Shock and Temporary Mechanical Circulatory Support.

Adnan Khalif1, Tiffany DuMont, Karthikeyan Ranganathan

  • 1Department of Interventional Cardiology, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, Pennsylvania (Drs Khalif and Ranganathan) and Division of Pulmonary Critical Care Medicine, School of Nursing, Ryerson University, Toronto, Ontario, Canada (Dr DuMont).

Critical Care Nursing Quarterly
|May 26, 2022
PubMed
Summary

Cardiogenic shock, a critical condition of circulatory collapse from heart failure, necessitates advanced hemodynamic support. This overview details cardiogenic shock presentations and temporary mechanical circulatory support devices for improved patient outcomes.

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

22.2K

Related Experiment Videos

Last Updated: Sep 22, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K
The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

22.2K

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • Cardiogenic shock is circulatory collapse from heart failure (left, right, or biventricular dysfunction).
  • Acute myocardial infarction is the primary cause, but end-stage heart failure is an increasing cause.
  • Patients present complex challenges in cardiac intensive care units, requiring hemodynamic support.

Purpose of the Study:

  • To provide an overview of cardiogenic shock.
  • To describe phenotypic clinical presentations of cardiogenic shock.
  • To detail temporary mechanical circulatory support devices used in management.

Main Methods:

  • Literature review of cardiogenic shock and mechanical circulatory support devices.
  • Analysis of clinical presentations and management strategies.
  • Synthesis of current knowledge on temporary mechanical circulatory support.

Main Results:

  • Cardiogenic shock results from severe heart failure, leading to low cardiac output and circulatory collapse.
  • Increasing prevalence of end-stage heart failure contributes to cardiogenic shock presentations.
  • Temporary mechanical circulatory support devices are crucial for improving perfusion and reducing mortality.

Conclusions:

  • Cardiogenic shock management requires understanding its varied presentations.
  • Temporary mechanical circulatory support devices are essential tools for critically ill patients.
  • This overview aids clinicians in managing complex cardiogenic shock cases.